...

Aptarro Launches Prism to Deliver Reimbursement Intelligence and Stop Denials Before They Happen

reimbursement intelligence

Aptarro today announced Prism, its new reimbursement intelligence platform. The company also introduced RemitIntel, the first product built on Prism. Provider groups, EHR and practice management partners, billing firms, and RCM services organizations can use RemitIntel now. Additionally, Aptarro will roll out more Prism capabilities through 2027.

Prism turns decades of reimbursement signals into usable intelligence. These signals span half a billion transactions. Moreover, the platform grows sharper with every claim, remittance, and outcome. It delivers insights inside the clinical and revenue cycle workflows teams already use. As a result, teams can see where reimbursement is at risk. They also learn what to change and act before preventable problems become denials.

Jeff Diamond, CEO of Aptarro, explained the thinking behind the launch.

“Every practice loses revenue to denials it could have prevented, and many can’t tell you which ones or why,” said Jeff Diamond, CEO of Aptarro. “Much of the industry learns from its own denials, one organization at a time. Prism changes the scale of that learning by connecting reimbursement signals across Aptarro’s network and bringing that experience to the decisions that matter next.”

RemitIntel Brings Payer Behavior Into Focus

RemitIntel serves as Prism’s remittance learning layer. Revenue cycle teams can see how payers adjudicate claims. They can also track policy changes across a network that no single practice could see alone. Then, RemitIntel converts that network intelligence into evidence-backed recommendations. Teams approve these recommendations before moving them into production within Aptarro’s flagship products, RCx and ClaimStaker. Consequently, teams carry lessons from one claim into a better decision on the next. The same denial does not happen twice.

Prism delivers reimbursement intelligence in two ways. First, it embeds insights at the point of decision inside clinical and revenue cycle software. Second, it offers Intelligence-as-a-Service for partners that want to build reimbursement capabilities into their own platforms and products. Over time, Prism will reach every stage of the revenue cycle. These stages include scheduling, prior authorization, coding, claim submission, remittance, and denial management.

Pilot Results Show Strong Validation

RemitIntel reimbursement intelligence already runs with pilot customers. It surfaces opportunities that traditional denial reporting misses. Across all pilots, 100% of recommended signals have been validated. At Vision Innovation Partners (VIP), one of the nation’s largest ophthalmology groups, preventable denials fell 50% over six months.

Duane Sheldon, Revenue Cycle Director at VIP, commented on the results.

“RemitIntel identifies trends in ways my own team hasn’t and has given me a path to action them,” commented Duane Sheldon, Revenue Cycle Director at VIP.

Prism rests on 40 years of revenue cycle experience. More than 130,000 providers fuel it, and they process 500 million transactions annually. Aptarro built its proprietary data and intelligence through decades of production experience with payer policy, coding, and reimbursement outcomes. Competitors cannot easily replicate that depth. Meanwhile, customer data stays isolated, and Aptarro never exposes it to another customer. Instead, what one organization learns becomes statistical reimbursement signals for the next decision. Aptarro does this without pooling identifiable customer data.

Diamond also highlighted the company’s long track record and its goals for providers.

“We’ve been building reimbursement intelligence for 40 years,” said Diamond. “Today, Prism brings together production experience, AI, and the scale of our network so that every outcome makes the next decision smarter. The goal is simple: help providers and the partners protect more of the revenue they’ve earned, get paid faster, spend less time fixing what should have been right, and make better reimbursement decisions as the market changes.”

Looking for more updates on financial innovation and revenue-driven technology? Visit RevTech News for expert insights and the latest trends.

News Source: Businesswire.com